A Study to Learn About the Study Medicine Called Tafamidis 61mg in People Diagnosed With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Clinical trial NCT06321523 · COMPLETED

Trial details

NCT number: NCT06321523
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Transthyretin Amyloid Cardiomyopathy

Start date: 2024-03-19
Primary completion: 2025-10-13
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.